UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
25
NOTIFICATION
OF REMOVAL FROM LISTING
AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Commission
File Number: 001-32639
|
Name
of Issuer: Manhattan Pharmaceuticals, Inc.
Exchange:
American Stock Exchange
|
(Exact
name of Issuer as specified in its charter, and name of Exchange where security
is listed and/or registered)
810
Seventh Avenue, 4th Floor, New York, New York 10019
(Address,
including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
common
stock, par value $0.001 per share
(Description
of class of securities)
Please
place an X in the box to designate the rule provision relied upon to strike
the
class of securities from listing and registration:
| o |
17
CFR 240.12d2-2(a)(1)
|
| o |
17
CFR 240.12d2-2(a)(2)
|
| o |
17
CFR 240.12d2-2(a)(3)
|
| o |
17
CFR 240.12d2-2(a)(4)
|
o Pursuant
to 17 CFR 240.12d2-2(b), the Exchange has
complied with its rules to strike the class of securities from listing and/or
withdraw registration on the Exchange.
x Pursuant
to 17 CFR
240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the
requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of
the
class of securities from listing and registration on the Exchange.
Pursuant
to the requirements of the Securities Exchange Act of 1934, Manhattan
Pharmaceuticals, Inc.
(Name of
Issuer or Exchange) certifies that it has reasonable grounds to believe that
it
meets all of the requirements for filing the Form 25 and has caused this
notification to be signed on its behalf by the undersigned duly authorized
person.
|
March
10, 2008
|
By:
/s/ Michael G. McGuinness
|
Chief
Financial Officer
|
|
Date
|
Name
|
Title
|